Acadian Asset Management LLC Pds Biotechnology Corp Transaction History
Acadian Asset Management LLC
- $57.3 Billion
- Q3 2025
A detailed history of Acadian Asset Management LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 61,793 shares of PDSB stock, worth $52,524. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,793Holding current value
$52,524% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
59Shares Held
7.76MCall Options Held
280KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$1.9 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.9MShares$1.62 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$413,9210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA482KShares$409,6990.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il386KShares$328,4650.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $24.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...